Curcumol alleviates cardiac remodeling via the AKT/NF-κB pathway

Area of Science:

• Cardiovascular Research
• Molecular Biology
• Pharmacology

Background:

• Cardiac remodeling is a critical, yet poorly understood, process in cardiovascular diseases, often leading to heart failure.
• Current treatment options for cardiac remodeling are limited, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

• To investigate the protective effects of curcumol against cardiac remodeling.
• To elucidate the underlying molecular mechanisms of curcumol's action in cardiac remodeling.

Main Methods:

• Utilized an isoproterenol (ISO)-induced animal model to study cardiac remodeling.
• Assessed curcumol's effects on cardiac function, fibrosis, hypertrophy, and electrical remodeling.
• Investigated curcumol's impact on inflammation and apoptosis in myocardial and cardiomyocyte models.
• Explored the role of the AKT/NF-κB signaling pathway in mediating curcumol's effects.

Main Results:

• Curcumol significantly attenuated cardiac dysfunction, myocardial fibrosis, and hypertrophy in the ISO-induced model.
• Curcumol alleviated cardiac electrical remodeling, reducing the risk of ventricular fibrillation.
• Curcumol inhibited ISO- and TGF-β1-induced inflammation and apoptosis.
• Curcumol's protective effects were mediated by inhibiting the AKT/NF-κB pathway, as evidenced by an AKT agonist reversing its benefits.

Conclusions:

• Curcumol demonstrates significant protective effects against cardiac remodeling.
• Curcumol's therapeutic potential lies in its ability to inhibit inflammation, apoptosis, and fibrosis via the AKT/NF-κB pathway.
• Curcumol represents a promising candidate for the development of novel treatments for cardiac remodeling and associated cardiovascular diseases.